Bandhan BSE Healthcare Index Fund
The scheme seeks to replicate the BSE Healthcare Index by investing in securities of the BSE Healthcare Index in the same proportion / weightage with an aim to provide returns before expenses that track the total return of BSE Healthcare Index, subject to tracking errors.
Growthvine rating: 1/5 — ranked #227 of 245 in category.
Fund basics
| Category | Equity: Index |
|---|
| NAV | ₹10.94 (as of 2026-10-22) |
|---|
| AUM | ₹21 Cr |
|---|
| Expense ratio | 0.88% |
|---|
| Riskometer | Very High |
|---|
| Fund manager | Abhishek Jain |
|---|
| Exit load | 0.25% for redemption within 15 days |
|---|
Performance & risk
| Standard deviation | 0.00% |
|---|
| Max drawdown | −16.28% |
|---|
| Alpha | 0 |
|---|
| Beta | 0 |
|---|
Market cap allocation
| Large cap | 33.3% |
|---|
| Mid cap | 38.5% |
|---|
| Small cap | 28.2% |
|---|
Concentration
| Top 5 holdings | 34.7% |
|---|
| Top 10 holdings | 53.3% |
|---|
| Total holdings | 137 |
|---|
Top holdings
- Sun Pharmaceutical Industries Ltd. — 12.4%
- Divis Laboratories Ltd. — 7.4%
- Apollo Hospitals Enterprises Ltd. — 5.2%
- Laurus Labs Limited — 4.8%
- Cipla Ltd. — 4.8%
- Dr. Reddys Laboratories Ltd. — 4.7%
- Max Healthcare Institute Limited — 4.3%
- Torrent Pharmaceuticals Ltd. — 3.6%
- Lupin Ltd — 3.1%
- Aurobindo Pharma Ltd. — 2.9%
Top sectors
- Pharma & Biotech — 78.1%
- Healthcare — 22.0%
- Cash — −0.2%
Calendar-year track record
| Year | Return | Quartile | Category rank |
|---|
| 2026 (partial) | 9.5% | — | — |
| 2025 | −3.8% | — | — |